Tag: Greg Hudalla

New approach to treat chronic inflammation offers potential for safer and more effective therapies

Drs. Gregory Hudalla, Benjamin Keselowsky, and team members have a new paper published in the high-profile interdisciplinary research journal Nature Biomedical Engineering. The paper is entitled, Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenase. Current treatments for chronic inflammation, such… Read More